These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3568537)

  • 21. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nifedipine on antipyrine and theophylline disposition.
    Adebayo GI; Mabadeje AF
    Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
    Harman AW; Penhall RK; Priestly BG; Frewin DB; Phillips PJ; Clarkson AR
    Aust N Z J Med; 1977 Aug; 7(4):385-90. PubMed ID: 270989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
    Schellens JH; van der Wart JH; Danhof M; van der Velde EA; Breimer DD
    Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzo(a)pyrene metabolism and plasma elimination rates of phenacetin, acetanilide and theophylline in man.
    Kellermann G; Luyten-Kellermann M
    Pharmacology; 1978; 17(4):191-200. PubMed ID: 693568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of human antipyrine metabolism by piroxicam.
    Battellino LJ; Dorronsoro de Cattoni ST; Ragagnin C
    Can J Physiol Pharmacol; 1990 Jun; 68(6):711-7. PubMed ID: 2372742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ; Purba HS; Park BK; Ward SA; Orme ML
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach.
    Schellens JH; Janssens AR; van der Wart JH; van der Velde EA; Breimer DD
    Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of cigarette smoking and sex on theophylline disposition.
    Powell JR; Thiercelin JF; Vozeh S; Sansom L; Riegelman S
    Am Rev Respir Dis; 1977 Jul; 116(1):17-23. PubMed ID: 879596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.
    Blyden GT; Greenblatt DJ; LeDuc BW; Scavone JM
    Eur J Clin Pharmacol; 1988; 35(4):413-7. PubMed ID: 3197750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of fever on antipyrine metabolism in children.
    Forsyth JS; Moreland TA; Rylance GW
    Br J Clin Pharmacol; 1982 Jun; 13(6):811-5. PubMed ID: 7093111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors contributing to the accelerated clearance of theophylline and antipyrine in adults with exocrine pancreatic disease.
    Acheson DW; Hunt LP; Rose P; Houston JB; Braganza JM
    Clin Sci (Lond); 1989 Apr; 76(4):377-85. PubMed ID: 2714050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
    Wanwimolruk S; Nyika S; Kepple M; Ferry DG; Clark CR
    J Pharm Pharmacol; 1993 Jul; 45(7):618-21. PubMed ID: 8105056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample.
    Loft S; Nielsen AJ; Borg BE; Poulsen HE
    Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of theophylline metabolism by long-term allopurinol administration.
    Manfredi RL; Vesell ES
    Clin Pharmacol Ther; 1981 Feb; 29(2):224-9. PubMed ID: 7460486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saliva and plasma clearance of antipyrine as reflectors of liver function.
    Luoma PV; Sotaniemi EA
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):261-4. PubMed ID: 7333326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between phenazone (antipyrine) metabolite formation and theophylline metabolism in healthy and frail elderly women.
    Groen K; Horan MA; Roberts NA; Gulati RS; Miljkovic B; Jansen EJ; Paramsothy V; Breimer DD; van Bezooijen CF
    Clin Pharmacokinet; 1993 Aug; 25(2):136-44. PubMed ID: 8403737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.